Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001562180-23-006457

Options or other derivatives

  • Chief Business Officer acquired 220,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Derakhshan Behrad · Chief Business Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-08-17 Grant or award : show line 1 in the form Stock Option (Right to Buy) +220,000 220,000 D
Loading xslF345X05/primarydocument.xml…